These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18078659)

  • 41. The rosigliazone meta-analysis: lessons for the future.
    Shuster JJ; Schatz DA
    Diabetes Care; 2008 Mar; 31(3):e10. PubMed ID: 18308673
    [No Abstract]   [Full Text] [Related]  

  • 42. Massive bilateral pleural effusion associated with use of pioglitazone.
    Chen YW; Chen YC; Wu CJ; Chen HH
    Clin Ther; 2008 Aug; 30(8):1485-9. PubMed ID: 18803990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
    Freemantle N
    BMJ; 2005 Oct; 331(7520):836-8. PubMed ID: 16210286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Australian government tries to stop independent advice on diabetes drugs.
    Burton B
    BMJ; 2003 Dec; 327(7428):1368. PubMed ID: 14670876
    [No Abstract]   [Full Text] [Related]  

  • 45. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Don't judge all glitazones alike!].
    Sjöholm A
    Lakartidningen; 2007 Oct 24-30; 104(43):3205. PubMed ID: 18018940
    [No Abstract]   [Full Text] [Related]  

  • 47. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
    Wilcox R; Kupfer S; Erdmann E;
    Am Heart J; 2008 Apr; 155(4):712-7. PubMed ID: 18371481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.
    Polonsky T; Mazzone T; Davidson M
    Trends Cardiovasc Med; 2009 Apr; 19(3):94-9. PubMed ID: 19679266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes prevention: still no effective drugs.
    Prescrire Int; 2007 Dec; 16(92):258. PubMed ID: 18095391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Options sought after drug study. Patients who take rosiglitazone might consider pioglitazone instead.
    Heart Advis; 2007 Jul; 10(7):9. PubMed ID: 17703512
    [No Abstract]   [Full Text] [Related]  

  • 52. Actos and Avandia in type 2 diabetes. Where do they fit?
    Clark W
    Diabetes Self Manag; 2007; 24(4):8, 11-3. PubMed ID: 17663078
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis.
    Abe M; Kikuchi F; Okada K; Matsumoto K
    Ther Apher Dial; 2009 Jun; 13(3):238-9. PubMed ID: 19527473
    [No Abstract]   [Full Text] [Related]  

  • 54. The cage in search of a bird.
    Kalra S
    J Assoc Physicians India; 2012 Jan; 60():74-5. PubMed ID: 22715551
    [No Abstract]   [Full Text] [Related]  

  • 55. DREAM and ADOPT: rosiglitazone does what it says on the packet.
    Bilous R
    Diabet Med; 2007 Feb; 24(2):107-9. PubMed ID: 17257270
    [No Abstract]   [Full Text] [Related]  

  • 56. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
    Odom J; Williamson B; Carter L
    Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rosiglitazone--statistics for benefits and problems].
    Hjelmesaeth J; Røislien J
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2702-3. PubMed ID: 17952157
    [No Abstract]   [Full Text] [Related]  

  • 58. Responding to an FDA warning--geographic variation in the use of rosiglitazone.
    Shah ND; Montori VM; Krumholz HM; Tu K; Alexander GC; Jackevicius CA
    N Engl J Med; 2010 Nov; 363(22):2081-4. PubMed ID: 21083379
    [No Abstract]   [Full Text] [Related]  

  • 59. [Is there a need of glitazones in the treatment of diabetes?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2124; author reply 2124. PubMed ID: 17717584
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus.
    Harashima K; Hayashi J; Miwa T; Tsunoda T
    Metabolism; 2009 Jun; 58(6):739-45. PubMed ID: 19446110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.